Dear Colleagues,
The HPRA in Ireland recently announced that it will support RMS switch free of charge for MAHs which hold a marketing authorisation in Ireland where IE are CMS and UK are RMS. The HPRA will also provide support to marketing authorisation holders (MAHs) so as to maintain the availability of medicines and is available to meet with and discuss any issues as required. Please see notes from the HPRA Brexit meeting in Aug 2017 here.
Kind regards,
Karen.
------------------------------
Karen Real
Director
Real Regulatory Ltd
London
United Kingdom
------------------------------